330 related articles for article (PubMed ID: 21198703)
1. Systematic review: Clostridium difficile and inflammatory bowel disease.
Goodhand JR; Alazawi W; Rampton DS
Aliment Pharmacol Ther; 2011 Feb; 33(4):428-41. PubMed ID: 21198703
[TBL] [Abstract][Full Text] [Related]
2. Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus.
Li Y; Xu H; Xu T; Xiao M; Tang H; Wu D; Tan B; Li J; Yang H; Lv H; Xu Y; Qian J
Dig Dis Sci; 2018 Nov; 63(11):3074-3083. PubMed ID: 30094621
[TBL] [Abstract][Full Text] [Related]
3. Clostridium difficile infection in patients with inflammatory bowel disease: a case control study.
Vitikainen K; Haapamäki J; Färkkilä M; Anttila VJ; Arkkila P
Scand J Gastroenterol; 2018 Aug; 53(8):947-951. PubMed ID: 30041549
[TBL] [Abstract][Full Text] [Related]
4. Escalation of Immunosuppressive Therapy for Inflammatory Bowel Disease Is Not Associated With Adverse Outcomes After Infection With Clostridium difficile.
Lukin DJ; Lawlor G; Hudesman DP; Durbin L; Axelrad JE; Passi M; Cavaliere K; Coburn E; Loftus M; Jen H; Feathers A; Rosen MH; Malter LB; Swaminath A;
Inflamm Bowel Dis; 2019 Mar; 25(4):775-781. PubMed ID: 30312400
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile infection and inflammatory bowel disease: what gastroenterologists and surgeons should know.
Cojocariu C; Trifan A; Stoica O; Chihaia CA; Stanciu C
Chirurgia (Bucur); 2014; 109(5):579-83. PubMed ID: 25532244
[TBL] [Abstract][Full Text] [Related]
6. Incidence and risk factors of Clostridium difficile infection in patients with inflammatory bowel disease.
Stoica O; Trifan A; Cojocariu C; Gîrleanu I; Maxim R; Stanciu MC
Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):81-6. PubMed ID: 25970947
[TBL] [Abstract][Full Text] [Related]
7. Management of inflammatory bowel disease with
D'Aoust J; Battat R; Bessissow T
World J Gastroenterol; 2017 Jul; 23(27):4986-5003. PubMed ID: 28785153
[TBL] [Abstract][Full Text] [Related]
8. Systematic review with meta-analysis: the impact of Clostridium difficile infection on the short- and long-term risks of colectomy in inflammatory bowel disease.
Law CC; Tariq R; Khanna S; Murthy S; McCurdy JD
Aliment Pharmacol Ther; 2017 Apr; 45(8):1011-1020. PubMed ID: 28206678
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Khoruts A; Rank KM; Newman KM; Viskocil K; Vaughn BP; Hamilton MJ; Sadowsky MJ
Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1433-8. PubMed ID: 26905904
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and clinical outcome of Clostridium difficile infection in patients with IBD: A single-center retrospective study of 260 cases in China.
Gu YB; Zhang MC; Sun J; Lv KZ; Zhong J
J Dig Dis; 2017 Apr; 18(4):207-211. PubMed ID: 28251812
[TBL] [Abstract][Full Text] [Related]
11. Impact of Clostridium difficile on inflammatory bowel disease.
Ananthakrishnan AN; Binion DG
Expert Rev Gastroenterol Hepatol; 2010 Oct; 4(5):589-600. PubMed ID: 20932144
[TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile infection and inflammatory bowel disease.
Cojocariu C; Stanciu C; Stoica O; Singeap AM; Sfarti C; Girleanu I; Trifan A
Turk J Gastroenterol; 2014 Dec; 25(6):603-10. PubMed ID: 25599768
[TBL] [Abstract][Full Text] [Related]
13. Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease.
Singh H; Nugent Z; Yu BN; Lix LM; Targownik LE; Bernstein CN
Gastroenterology; 2017 Aug; 153(2):430-438.e2. PubMed ID: 28479377
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile and inflammatory bowel disease.
Ananthakrishnan AN; Issa M; Binion DG
Gastroenterol Clin North Am; 2009 Dec; 38(4):711-28. PubMed ID: 19913210
[TBL] [Abstract][Full Text] [Related]
15. Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.
Solanky D; Pardi DS; Loftus EV; Khanna S
Inflamm Bowel Dis; 2019 Feb; 25(3):610-619. PubMed ID: 30260451
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection.
Ben-Horin S; Margalit M; Bossuyt P; Maul J; Shapira Y; Bojic D; Chermesh I; Al-Rifai A; Schoepfer A; Bosani M; Allez M; Lakatos PL; Bossa F; Eser A; Stefanelli T; Carbonnel F; Katsanos K; Checchin D; de Miera IS; Reinisch W; Chowers Y; Moran GW;
J Crohns Colitis; 2010 Jun; 4(2):194-8. PubMed ID: 21122505
[TBL] [Abstract][Full Text] [Related]
17. Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients.
Hughes M; Qazi T; Berg A; Weinberg J; Chen X; Kelly CP; Farraye FA
Inflamm Bowel Dis; 2016 Apr; 22(4):853-61. PubMed ID: 26954708
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece.
Viazis N; Pontas C; Karmiris K; Dimas I; Fragaki M; Paspatis G; Drygiannakis I; Koutroubakis IE; Moschovis D; Tzouvala M; Theocharis G; Tsolias C; Thomopoulos K; Zampeli E; Axiaris G; Michopoulos S; Belesiotou E; Banasa M; Maraki S; Kouskoumpekou F; Apostolopoulos G; Stamouli V; Prifti H; Mantzaris GJ
Eur J Gastroenterol Hepatol; 2019 Jul; 31(7):773-776. PubMed ID: 30973416
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile infection in the inflammatory bowel disease patient.
Berg AM; Kelly CP; Farraye FA
Inflamm Bowel Dis; 2013 Jan; 19(1):194-204. PubMed ID: 22508484
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile infection and inflammatory bowel disease.
Reddy SS; Brandt LJ
J Clin Gastroenterol; 2013 Sep; 47(8):666-71. PubMed ID: 23507767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
